X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3853) 3853
Publication (505) 505
Dissertation (23) 23
Book Chapter (22) 22
Government Document (22) 22
Book Review (16) 16
Newsletter (3) 3
Conference Proceeding (2) 2
Magazine Article (2) 2
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2370) 2370
cyclin e - metabolism (1499) 1499
animals (1488) 1488
index medicus (1435) 1435
cell cycle (1333) 1333
cyclin e (1190) 1190
oncology (1060) 1060
female (1020) 1020
cell biology (980) 980
expression (866) 866
cyclin-e (823) 823
cyclin e - genetics (783) 783
mice (779) 779
cancer (759) 759
apoptosis (741) 741
biochemistry & molecular biology (735) 735
cell proliferation (725) 725
phosphorylation (709) 709
cell line, tumor (671) 671
proteins (625) 625
male (590) 590
cyclin-dependent kinase 2 (542) 542
proliferation (505) 505
gene expression (453) 453
immunohistochemistry (429) 429
middle aged (429) 429
cell cycle proteins - metabolism (401) 401
research (385) 385
signal transduction (372) 372
cyclin-dependent kinases - metabolism (368) 368
cyclin d1 - metabolism (365) 365
p27 (364) 364
cyclin-dependent kinase inhibitor p27 (352) 352
prognosis (351) 351
aged (347) 347
cells, cultured (333) 333
adult (332) 332
gene expression regulation, neoplastic (330) 330
kinases (329) 329
cell-cycle (328) 328
breast cancer (323) 323
cell line (320) 320
cyclin d1 (316) 316
cyclins - metabolism (316) 316
breast-cancer (314) 314
blotting, western (313) 313
growth (310) 310
cdc2-cdc28 kinases (309) 309
g1 phase (308) 308
activation (307) 307
genetic aspects (306) 306
cell proliferation - drug effects (300) 300
protein-serine-threonine kinases - metabolism (297) 297
protein (292) 292
retinoblastoma protein (287) 287
rats (286) 286
cyclin e - biosynthesis (285) 285
cyclin-dependent kinase 2 - metabolism (285) 285
down-regulation (285) 285
p53 (285) 285
s-phase (284) 284
cyclin-dependent kinase inhibitor p21 (282) 282
mutation (280) 280
genetics & heredity (278) 278
s phase (277) 277
transfection (273) 273
tumors (272) 272
retinoblastoma protein - metabolism (271) 271
cell growth (264) 264
analysis (263) 263
tumor cells, cultured (263) 263
flow cytometry (259) 259
cell cycle proteins - genetics (257) 257
cell cycle - drug effects (256) 256
cell division (250) 250
article (248) 248
cell cycle proteins (244) 244
gene (242) 242
cell cycle - physiology (241) 241
oncogene proteins - metabolism (241) 241
progression (238) 238
research article (232) 232
overexpression (229) 229
gene-expression (227) 227
multidisciplinary sciences (225) 225
cyclin-dependent kinases (223) 223
biology (222) 222
apoptosis - drug effects (214) 214
oncogene proteins - genetics (212) 212
breast neoplasms - pathology (210) 210
differentiation (210) 210
cyclin a - metabolism (207) 207
cells (206) 206
cyclins (205) 205
survival (205) 205
cyclin-dependent kinase 4 (204) 204
rna, messenger - metabolism (204) 204
medicine (202) 202
inhibition (200) 200
transcription factors - metabolism (200) 200
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3788) 3788
Chinese (89) 89
Portuguese (12) 12
Japanese (7) 7
Spanish (7) 7
Korean (4) 4
French (3) 3
Polish (3) 3
Italian (2) 2
Russian (2) 2
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 10/2018, Volume 78, Issue 20, pp. 5901 - 5906
The homeodomain transcription factor PROX1 has been linked to several cancer types, including gliomas, but its functions remain to be further elucidated. Here... 
TRANSCRIPTION FACTORS | CYCLIN-E | ONCOLOGY | HUMAN-MALIGNANT GLIOMA | TUMOR | CENTRAL-NERVOUS-SYSTEM | PROLIFERATION | GROWTH-FACTOR | DIFFERENTIATION | PROGRESSION | CANCER STEM-CELLS
Journal Article
Hepatology Research, ISSN 1386-6346, 09/2012, Volume 42, Issue 9, pp. 904 - 910
Aim:  F‐box and WD repeat domain‐containing 7 (Fbxw7) is a cell cycle regulatory gene that targets for ubiquitination and proteasomal degradation various cell... 
cyclin E | Fbxw7 | c‐Myc | hepatocellular carcinoma | p53 | C-Myc | Hepatocellular carcinoma | Cyclin E | P53 | TARGET | FBXW7/HCDC4 | UBIQUITIN-PROTEASOME SYSTEM | c-Myc | MULTISITE PHOSPHORYLATION | AMPLIFICATION | GENE | GROWTH | TUMOR-SUPPRESSOR | HEPATITIS-B | PROTEINS | GASTROENTEROLOGY & HEPATOLOGY | Immunohistochemistry | Ubiquitin | Liver cancer | Medical colleges | Messenger RNA | Analysis | Genes | Hepatoma | Tumor proteins | Health aspects
Journal Article
Journal Article
Toxicological Sciences, ISSN 1096-6080, 11/2007, Volume 100, Issue 1, pp. 180 - 193
Halogenated agonists for the aryl hydrocarbon receptor (AHR), such as 3,3′,4,4′,5-pentachlorobiphenyl (PCB126) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),... 
Embryotoxicity | 3,3′,4,4′,5-pentachlorobiphenyl (PCB126) | Cytochrome P450 1 (CYP1) | PCNA | 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) | Aryl hydrocarbon receptor (AHR) | 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) | DANIO-RERIO | DIOXIN | CIRCULATION FAILURE | FUNDULUS-HETEROCLITUS | aryl hydrocarbon receptor (AHR) | 3,3 ',4,4 ',5-pentachlorobiphenyl (PCB126) | DEVELOPMENTAL TOXICITY | HEART | RETINOBLASTOMA PROTEIN | MESSENGER-RNA | ARYL-HYDROCARBON RECEPTOR | BIPHENYL CONGENERS | embryotoxicity | TOXICOLOGY | cytochrome P450 1 (CYP1) | Gene Expression Regulation, Enzymologic - drug effects | Heart Defects, Congenital - chemically induced | Transcriptional Activation | Zebrafish - abnormalities | Embryo, Nonmammalian - metabolism | Oligonucleotides, Antisense - metabolism | Cytochrome P-450 Enzyme System - metabolism | Zebrafish - embryology | Embryo, Nonmammalian - drug effects | Dose-Response Relationship, Drug | Time Factors | Isoenzymes - metabolism | Cell Cycle Proteins - genetics | Receptors, Aryl Hydrocarbon - metabolism | Zebrafish Proteins - agonists | Environmental Pollutants - toxicity | Craniofacial Abnormalities - metabolism | Zebrafish Proteins - metabolism | Cell Cycle Proteins - metabolism | Gene Expression Regulation, Developmental - drug effects | Receptors, Aryl Hydrocarbon - genetics | Craniofacial Abnormalities - chemically induced | Aryl Hydrocarbon Hydroxylases - metabolism | Receptors, Aryl Hydrocarbon - agonists | Edema - metabolism | Embryo, Nonmammalian - abnormalities | Animals | Embryo, Nonmammalian - enzymology | Polychlorinated Biphenyls - toxicity | Zebrafish - metabolism | Cytochrome P-450 CYP1B1 | Cytochrome P-450 Enzyme System - genetics | Polychlorinated Dibenzodioxins - toxicity | Cell Proliferation - drug effects | Heart Defects, Congenital - metabolism | Cyclin E - metabolism | Edema - chemically induced | Zebrafish Proteins - genetics | Embryonic Development - drug effects | Proliferating Cell Nuclear Antigen - metabolism | 8-tetrachlorodibenzo-p-dioxin (TCDD); embryotoxicity | Biological Sciences | Naturvetenskap | Biologiska vetenskaper | 5-pentachlorobiphenyl (PCB126); 2 | Biology | Biologi | Natural Sciences | cytochrome P450 1 (CYP1); 3
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2011, Volume 6, Issue 11, p. e26122
MiR-34a acts as a candidate tumour suppressor gene, and its expression is reduced in several cancer types. We aimed to study miR-34a expression in breast... 
TARGET | APOPTOSIS | CELLS | BIOINFORMATICS | MICROARRAY | DNA-DAMAGE RESPONSE | BIOLOGY | DOWN-REGULATION | GENE-EXPRESSION | MICRORNAS | FAMILY | Carcinoma, Ductal, Breast - genetics | Prognosis | Oligonucleotide Array Sequence Analysis | Receptor, ErbB-2 - genetics | Tissue Array Analysis | Humans | Middle Aged | Gene Expression Profiling | Carcinoma, Ductal, Breast - mortality | Cyclin E - genetics | Carcinoma, Lobular - mortality | Tumor Suppressor Protein p53 - genetics | Neoplasm Grading | Carcinoma, Lobular - genetics | Female | Carcinoma, Ductal, Breast - secondary | Carcinoma, Lobular - secondary | RNA, Messenger - genetics | Survival Rate | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Breast Neoplasms - genetics | Histones - genetics | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Neoplasm Staging | Patient outcomes | Genes | Oncology, Experimental | Breast cancer | Genetic aspects | Metastasis | Research | Genetic transcription | DNA binding proteins | Tumor proteins | Cancer | Transcription factors | p53 Protein | DNA damage | Lung cancer | Oncology | Risk | Genomes | Multivariate analysis | Kinases | Metastases | Proteins | Cell growth | Cell cycle | DNA methylation | Cyclin E | Deoxyribonucleic acid--DNA | Medical research | Genomic analysis | Gynecology | Cyclin-dependent kinases | Health risks | Gene expression | ErbB-2 protein | Obstetrics | Pathology | MicroRNAs | Medical prognosis | Regulatory mechanisms (biology) | Breast | Mutation | Binding sites | Tumors | Apoptosis | Medical and Health Sciences | Medicin och hälsovetenskap | Deoxyribonucleic acid | DNA
Journal Article
PLoS Genetics, ISSN 1553-7390, 02/2018, Volume 14, Issue 2, p. e1007219
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 10/2014, Volume 29, Issue 10, pp. 1822 - 1829
Journal Article